Advertisement
Advertisement
ALC
Alcon Inc. Ordinary Shares
79.19
USDSponsored
+0.64
+0.81%
Feb 13, 16:00 UTC -5
Closed
After-Market
79.20
+0.02
+0.02%
ALC Earnings Reports
Positive Surprise Ratio
ALC beat 19 of 27 last estimates.
70%
Next Report
Date of Next Report
Mar 03, 2026
Estimate for Q4 25 (Revenue/ EPS)
$2.74B
/$0.79
Implied change from Q3 25 (Revenue/ EPS)
+5.94%
/--
Implied change from Q4 24 (Revenue/ EPS)
+10.73%
/+9.72%
Alcon Inc. Ordinary Shares earnings per share and revenue
On Nov 11, 2025, ALC reported earnings of 0.79 USD per share (EPS) for Q3 25, beating the estimate of 0.76 USD, resulting in a 2.89% surprise. Revenue reached 2.59 billion, compared to an expected 2.63 billion, with a -1.53% difference. The market reacted with a +2.69% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 14 analysts forecast an EPS of 0.79 USD, with revenue projected to reach 2.74 billion USD, implying an increase of 0.00% EPS, and increase of 5.94% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Edwards Lifesciences Corp
Report Date
Feb 10, 2026 For Q4 25
Estimate
$0.63
Actual
$0.57
Surprise
-8.85%
Mettler-Toledo International
Report Date
Feb 05, 2026 For Q4 25
Estimate
$12.92
Actual
$13.36
Surprise
+3.34%
DexCom, Inc.
Report Date
Feb 12, 2026 For Q4 25
Estimate
$0.66
Actual
$0.45
Surprise
-32.13%
Waters Corp
Report Date
Feb 09, 2026 For Q4 25
Estimate
$4.55
Actual
$4.53
Surprise
-0.49%
Artivion, Inc.
Report Date
Feb 12, 2026 For Q4 25
Estimate
$0.08
Actual
$0.05
Surprise
-39.98%
iRadimed Corporation
Report Date
Feb 10, 2026 For Q4 25
Estimate
$0.48
Actual
$0.54
Surprise
+10.29%
Pacific Biosciences of California, Inc.
Report Date
Feb 12, 2026 For Q4 25
Estimate
-$0.15
Actual
-$0.12
Surprise
+20.27%
Electromed, Inc.
Report Date
Feb 10, 2026 For Q2 26
Estimate
$0.27
Actual
$0.32
Surprise
+17.22%
CVRx, Inc. Common Stock
Report Date
Feb 12, 2026 For Q4 25
Estimate
-$0.44
Actual
-$0.46
Surprise
-2.77%
Sensus Healthcare, Inc
Report Date
Feb 12, 2026 For Q4 25
Estimate
-$0.07
Actual
-$0.19
Surprise
-166.11%
FAQ
What were Alcon Inc. Ordinary Shares's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Alcon Inc. Ordinary Shares reported EPS of $0.79, beating estimates by 2.89%, and revenue of $2.59B, -1.53% below expectations.
How did the market react to Alcon Inc. Ordinary Shares's Q3 2025 earnings?
The stock price moved up 2.69%, changed from $77.36 before the earnings release to $79.44 the day after.
When is Alcon Inc. Ordinary Shares expected to report next?
The next earning report is scheduled for Mar 03, 2026.
What are the forecasts for Alcon Inc. Ordinary Shares's next earnings report?
Based on 14
analysts, Alcon Inc. Ordinary Shares is expected to report EPS of $0.79 and revenue of $2.74B for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement